Sign in
4

Changes in Ownership

Arbutus Biopharma Corp Filed Acc 0001447028-20-000065

Options or other derivatives

  • Director acquired 22,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Cheng Andrew · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-05-28 Grant or award : show line 1 in the form Stock Options +22,000 22,000 D
Loading xslF345X03/wf-form4_159104509367362.xml…